Search

everythinglearnresearchcommunity

for

Search:↓

Erdr1 could be a new marker for diagnosing hair loss.

A woman's hair loss during Hepatitis C treatment with PEG-INF-a-2a and Ribavirin was reversible after stopping the medication.

A patient with a severe type of hair loss experienced partial hair regrowth after treatment with a specific light therapy and a medication called interferon α2a.

PPARα agonists may help treat alopecia areata by reducing inflammation.

Certain gene variations may increase the risk and severity of alopecia areata.

Leflunomide is more likely to help treat alopecia areata than cause it.

Vitamin D might help treat alopecia areata.

Imiquimod improved skin pigmentation in most patients with xeroderma pigmentosum and may prevent further skin cancer, but some treatments can have side effects.

People with certain skin diseases have higher levels of the hormone prolactin in their blood.

The health of the sentinel lymph node is the best indicator of survival for patients with thick skin cancer.

Upadacitinib effectively treated severe atopic dermatitis, vitiligo, and alopecia areata in one patient.

Alopecia areata patients may have higher blood pressure and blood sugar, indicating a future risk of metabolic issues.

Deucravacitinib improves symptoms and reduces inflammation in Lichen Planopilaris.

Upadacitinib improved multiple immune-related conditions in one patient.

JAK inhibitors effectively regrow hair in alopecia areata but hair loss often returns after stopping treatment.

Catechins-rich tea extract may help reduce hair loss and promote hair growth.

Baricitinib effectively regrows hair in severe alopecia areata cases.

Combining laser treatment with steroid cream is more effective for alopecia areata than using the cream alone.

Gut microbiota changes might play a role in alopecia areata, and microbiome-targeted treatments show promise.

Calcipotriol's effectiveness for treating alopecia areata is unclear and needs more research.

Frontal fibrosing alopecia can be managed with personalized combination therapies, but no cure exists yet.

Baricitinib treatment for alopecia universalis can cause hair regrowth with unexpected whitening.

Tofacitinib successfully treated vitiligo in a patient with lupus without side effects.

Upadacitinib may effectively treat alopecia areata without side effects.

SH-MSCs gel can effectively treat alopecia by increasing IL-10 and decreasing TNF-α gene expression.

PPAR-γ may be a key target for treating alopecia areata and other skin conditions.

COVID-19 may trigger or worsen rapid hair loss in alopecia areata.

Skin problems are common in lupus, often appearing first, with various types and treatments, and careful monitoring is important for diagnosis and management.

Oral ulcers are common in SLE patients and often link to other symptoms.

Topical corticosteroids are the preferred first treatment for children with Alopecia Areata.